HomeClinical TopicsFDA approves Levaquin for plague

FDA approves Levaquin for plague

Author(s):

On April 27, the U.S. Food and Drug Administration approved Levaquin (levofloxacin) to treat patients with plague. The drug was approved under the agency’s Animal Efficacy Rule, which allows efficacy findings from adequate and well-controlled animal studies to be used in cases where it is not feasible or ethical to conduct trials in humans. There are only 1,000 to 2,000 cases of plague worldwide, making it not possible to conduct adequate efficacy trials in humans. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

uterine fibroids

Do Vitamins, Plants Help Uterine Fibroid Risk or Treatment?

A research team out of Poland recently undertook a comprehensive examination of published data to determine the role that vitamins and diet might play...